Platelet Rich Plasma: A Market Snapshot by GlobalData

VIEWS: 893 PAGES: 8

More Info
									                                     Platelet Rich Plasma: A Market Snapshot
       Reference Code: GDME0720VPT                                                                                                 Publication Date: MAY 2010

                                                                                             2        Summary
       1          Table of Contents
                                                                                             The US Platelet Rich Plasma (PRP) market was valued at $45m in
       1  Table of Contents ..........................................................1      2009 and is forecast to reach $126m in 2016 growing at a
        1.1   List of Tables ..........................................................1     Compound Annual Growth Rate (CAGR) of 14% during 2009 to
        1.2   List of Figures.........................................................1
                                                                                             2016. Increasing use of PRP therapy in sports medicine is driving
       2 Summary .......................................................................1
       3 Platelet Rich Plasma: Market Snapshot ........................1                     the growth in the market. Biomet, Harvest Technologies, Depuy
        3.1   Overview ................................................................1     Orthopaedics, Cytomedix, Arteriocyte Medical Systems, and
        3.2   Platelet Rich Plasma Therapy Applications ............2                        Arthrex are the key companies in the PRP devices market.
        3.3   Platelet Rich Plasma, Market Drivers .....................3
        3.4   Platelet Rich Plasma, Market Restraints ................3                      In the last four years, PRP therapy has gained rapid recognition in
        3.5   Key Companies and Marketed Products ................4                          sports medicine. Many professional athletes have undergone PRP
       4 Appendix .......................................................................6   therapy and it was found to be beneficial in some of them with
        4.1   Research Methodology ..........................................6               atheletes recovering in a shorter time. Patients undergoing PRP
        4.2   Coverage................................................................6      therapy can experience benefits such as improvement in
        4.3   Secondary Research..............................................7              symptoms, elimination of the need for more traditional treatments
        4.4   Primary Research...................................................7
                                                                                             such as medications, cortisone injections or surgery, and a faster
        4.5   Models....................................................................8
        4.6   Forecasts ...............................................................8     return to fitness. This is resulting in PRP therapy being widely used
        4.7   Expert Panels .........................................................8       in sport medicine. In addition to sports it has potential applications
        4.8   GlobalData Consulting ...........................................8             in dental and cardiovascular markets. Clinical studies are
        4.9   Contact Us .............................................................8      underway to define its effect in these areas.
        4.10     Disclaimer..........................................................8
                                                                                             Limited research and the lack of long term clinical data is slowing
                                                                                             the physician adoption of PRP therapy. Physicians believe that
                                                                                             more randomized and controlled trials need to be performed on
       1.1       List of Tables                                                              PRP therapy with large patient populations and greater follow-up
           Table 1: Platelet Rich Plasma Market, US, Revenue                                 periods to prove it as an effective and potential treatment. Lack of
           ($m), 2009 – 2016.............................................................2   reimbursement is also one of the barriers to the adoption of PRP
           Table 2: Arthrex, ACP Product Summary.......................5                     therapy.
           Table 3: Comparison of Major Platelet Concentrate
           Systems Available.............................................................6   3        Platelet Rich Plasma: Market Snapshot
                                                                                             3.1      Overview
       1.2       List of Figures
                                                                                             PRP is prepared by drawing a small amount of blood from the
           Figure 1:....... Platelet Rich Plasma Market, US, Revenue
           ($m), 2009 – 2016............................................................2    patient and then subjecting it to centrifugation which sediments the
           Figure 2: GlobalData Methodology ...................................7             platelets. To get enough platelets from autologous blood, the
                                                                                             device must use a double centrifugation technique. The first spin
                                                                                             (called the hard spin) separates the red blood cells from the
                                                                                             plasma, which contains the platelets, the white blood cells, and the
                                                                                             clotting factors. The second spin (called the soft spin) finely
                                                                                             separates the platelets and white blood cells, together with a few
                                                                                             red blood cells from the plasma. This soft spin produces the PRP
                                                                                             and separates it from the Platelet Poor Plasma (PPP). The plasma
                                                                                             produced with a single spin would not yield true PRP; instead, it
                                                                                             would produce a mixture of PRP and PPP and would have low
                                                                                             platelet counts. Regardless of the rate of centrifugation or the time
                                                                                             of centrifugation, a single spin cannot adequately concentrate
                                                                                             platelets because the red blood cells will interfe
								
To top